CL2008001765A1 - Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections. - Google Patents

Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.

Info

Publication number
CL2008001765A1
CL2008001765A1 CL2008001765A CL2008001765A CL2008001765A1 CL 2008001765 A1 CL2008001765 A1 CL 2008001765A1 CL 2008001765 A CL2008001765 A CL 2008001765A CL 2008001765 A CL2008001765 A CL 2008001765A CL 2008001765 A1 CL2008001765 A1 CL 2008001765A1
Authority
CL
Chile
Prior art keywords
compound
preparation process
endo
benzamide
benzo
Prior art date
Application number
CL2008001765A
Other languages
Spanish (es)
Inventor
Jan Heeres
Paulus Joannes Lewwi
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CL2008001765A1 publication Critical patent/CL2008001765A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos derivados de benzo[d]isoxazolil benzamida; procedimiento de preparación; composición farmacéutica que comprende a dicho compuesto; procedimiento de preparación; y uso del compuesto en el tratamiento de infecciones por endo- y ectoparásitos.Compounds derived from benzo [d] isoxazolyl benzamide; preparation procedure; pharmaceutical composition comprising said compound; preparation procedure; and use of the compound in the treatment of endo- and ectoparasite infections.

CL2008001765A 2007-06-15 2008-06-13 Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections. CL2008001765A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07110338 2007-06-15

Publications (1)

Publication Number Publication Date
CL2008001765A1 true CL2008001765A1 (en) 2008-12-19

Family

ID=38603183

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001765A CL2008001765A1 (en) 2007-06-15 2008-06-13 Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.

Country Status (5)

Country Link
AR (1) AR066980A1 (en)
CL (1) CL2008001765A1 (en)
PA (1) PA8783901A1 (en)
TW (1) TW200916100A (en)
WO (1) WO2008152081A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102206152A (en) * 2011-04-12 2011-10-05 浙江荣耀化工有限公司 Method for chemically synthesizing 3,5-diio-2-hydroxybenzene formyl chloride

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621597A (en) *
ZA731553B (en) * 1972-03-07 1974-10-30 Janssen Pharmaceutica Nv Salicylanilide derivatives
DE2220629C3 (en) * 1972-04-27 1981-01-22 Bayer Ag, 5090 Leverkusen Benzisoxazolo (thiono) phosphorus (phosphonic) acid esters, process for their preparation and their use as insecticides and acaricides
US4005218A (en) * 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
US4212865A (en) * 1978-12-26 1980-07-15 Riker Laboratories, Inc. Amine derivatives of 2-nitro-3-phenylbenzofuran
US5256681A (en) * 1989-03-15 1993-10-26 Janssen Pharmaceutica N.V. [5(6)-(benzisoxa-,benzisothia-or indazol-3-yl)-1H-benzimidazol-2-yl]carbamates

Also Published As

Publication number Publication date
PA8783901A1 (en) 2009-01-23
WO2008152081A3 (en) 2009-05-28
WO2008152081A2 (en) 2008-12-18
AR066980A1 (en) 2009-09-23
TW200916100A (en) 2009-04-16

Similar Documents

Publication Publication Date Title
CL2007001392A1 (en) Compounds derived from quinoline or benzopyran hiv replication inhibitors; pharmaceutical composition comprising said compounds; and its use in the treatment of a hiv infection
CL2008003406A1 (en) Quinoline derived compounds; pharmaceutical composition comprising them; and use in the treatment of an HIV infection.
CL2008002369A1 (en) Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer.
CL2008001855A1 (en) Boron-derived condensed cyclic compounds; pharmaceutical composition; and use in the treatment and / or prevention of an infectious disease.
CL2007000806A1 (en) COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
CL2007003686A1 (en) COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
CL2007002207A1 (en) COMPOUNDS DERIVED FROM SULFONYLAMINES; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS IN THE TREATMENT OF GLAUCOMA.
SV2009002865A (en) USE OF OXAZOLIDINONES FOR THE TREATMENT AND PROFILAXIS OF MICROANGIOPATIAS
CL2009000483A1 (en) Compounds derived from n- (pyridin-3-yl) -1,3-thiazole-5-amino-4-carboxamide, pim kinase inhibitors; pharmaceutical composition; and use for the treatment of cancer.
CL2007003250A1 (en) COMPOUNDS DERIVED FROM ISOQUINOLINE, INHIBITORS OF THE HEPATITIS C VIRUS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF AN HCV INFECTION.
CL2008001170A1 (en) Compounds derived from chromans and naphthalene substituted with a heterocyclic ring; pharmaceutical composition; and its use in the treatment of acute or chronic nociceptive pain or pain, visceral pain, inflammatory and / or central or peripheral neuropathic pain.
CL2007002018A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED ISOXAZOLINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF A DISEASE CAUSED BY AN INCREASE IN THE CELL PROLIFERATION.
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
CL2007001992A1 (en) COMPOUNDS DERIVED FROM PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGE DISEASE
CL2008003405A1 (en) Compounds derived from thienopyridine, inhibitors of the hiv integrase enzyme; pharmaceutical composition comprising said compounds; and its use to treat an HIV infection.
CL2007000601A1 (en) Compounds derived from pyrazolic heterobicycles, inhibitors of thyroxine kinase protein activity; pharmaceutical composition comprising said compounds; and use of the compounds in the treatment of a hyperproliferative disease.
CL2008003511A1 (en) Nucleotide derived compounds, hepatitis c virus ns5b polymerase inhibitors; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
CL2007002890A1 (en) Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
CL2007001205A1 (en) Compounds derived from n-phenyl-3-thio-4-phenyl-azetedin-2-one; preparation procedure; pharmaceutical composition; combination; use in the treatment of a hyperlipidemic condition, atherosclerosis, Alzheimer's and cholesterol-associated tumors
CL2011002925A1 (en) Isoquinolin-1 (2h) -one derived compounds, selective inhibitors of poly (adp-ribose) polymerase parp-1 activity; process to prepare them; pharmaceutical composition; and its use to treat a disease mediated by the protein parp-1.
CL2007002346A1 (en) NON-NUCLEOSIDIC COMPOUNDS DERIVED FROM FENOXI-FENIL SUBSTITUTED, INHIBITORS OF THE HIV REVERSE TRANSCRIPT; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT PREVENT AN HIV INFECTION OR TO TREAT AIDS OR CRS.
CL2007003540A1 (en) COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
CL2007000918A1 (en) COMPOUNDS DERIVED FROM ENFUMAFUNGINA, INHIBITORS OF (1,3) -BETA-D-GLUCANOSINTETASE; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A FUNGICAL INFECTION.
CL2008002049A1 (en) Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
CL2008002689A1 (en) Compounds derived from heterocycle 1,4 substituted piperidine; intermediate compounds; pharmaceutical composition; Preparation process; and its use in the treatment of Alzheimer's and schizophrenia.